Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Reyata® (atazanavir) – New warning, label updates
October 20, 2017 – The FDA approved an update to the Warnings and Precautions section of the Reyataz (atazanavir) drug label regarding chronic kidney disease.
